Viewing Study NCT00169156


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-04-09 @ 11:07 AM
Study NCT ID: NCT00169156
Status: COMPLETED
Last Update Posted: 2017-03-13
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
Sponsor: Lymphoma Study Association
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module